HS140 Unit 5 Drug Interaction Analysis Example

Reviewed by Elspeth Marlowe, MSN, RN Pharmacology Purdue University Global Free custom sample in 24 to 48h

The HS140 Unit 5 interaction analysis classifies five real drug pairs as pharmacokinetic or pharmacodynamic and explains each mechanism. Purdue Global HS 140 asks BS in Health Science learners to go beyond an interaction checker's warning to the reason behind it. Ciprofloxacin raises tizanidine levels about tenfold by blocking the enzyme that clears it. Trimethoprim-sulfamethoxazole with spironolactone raised hospital admissions for high potassium about twelvefold in older adults. Gabapentin with an opioid was linked to higher odds of opioid-related death. Allopurinol with azathioprine can suppress bone marrow, and fluoxetine with metoprolol can slow the heart. Sections on timing, food and herbal interactions and handoffs between prescribers complete the analysis.

CourseHS140 Pharmacology
UnitUnit 5
Paper typeInteraction analysis
LengthAbout 870 words, 6 pages double-spaced
FormatAPA 7 student paper
SchoolPurdue University Global
ProgramBS in Health Science
UpdatedOctober 2026

Free sample paper for HS140 Unit 5

1

Raised Levels and Stacked Effects: A Unit 5 Interaction Analysis of Five Drug Pairs, Classified by Mechanism

[Student Name]

Purdue University Global

HS140: Pharmacology

Unit 5 Interaction Analysis

[Instructor Name]

[Date]

The drug pairs are real and the mechanisms are drawn from the studies and textbooks cited; no doses are given.

What this part is doingSaying that some pairs carry measured evidence tells the reader the analysis rests on studies, not only on interaction-checker warnings.
2

Two Kinds of Interaction

In a pharmacokinetic interaction, the amount of a drug in the blood, or the time it stays there, shifts because one drug alters another's absorption, distribution, metabolism or excretion. A pharmacodynamic interaction changes what the drugs do at their site of action: their effects add together, oppose each other or combine in an unexpected way, without either level changing (Katzung & Vanderah, 2021). The question to ask is what changes, the amount of drug or the effect.

Pair 1: Ciprofloxacin and Tizanidine

Type: pharmacokinetic. Mechanism: tizanidine, a muscle relaxant, is broken down mainly by the liver enzyme CYP1A2. Ciprofloxacin, an antibiotic, strongly inhibits that enzyme. In healthy volunteers, ciprofloxacin raised tizanidine levels about tenfold and produced marked drops in blood pressure and strong sedation (Granfors et al., 2004). Watch for: low blood pressure, dizziness, excessive drowsiness. The combination is contraindicated.

Pair 2: Trimethoprim-Sulfamethoxazole and Spironolactone

Type: pharmacodynamic, with both drugs raising potassium by different routes. Mechanism: spironolactone blocks aldosterone, so the kidney keeps potassium; trimethoprim blocks sodium channels in the kidney tubule in a way that also reduces potassium excretion. In older adults taking spironolactone, a course of trimethoprim-sulfamethoxazole was associated with a twelvefold higher risk of hospital admission for high potassium compared with amoxicillin (Antoniou et al., 2011). Watch for: muscle weakness, abnormal heart rhythm, a rising potassium level; another antibiotic is often chosen.

Pair 3: Gabapentin and an Opioid

Type: pharmacodynamic. Mechanism: both depress the central nervous system, and together they can slow breathing more than either alone. In a population study of people taking opioids, those also taking gabapentin had higher odds of dying from an opioid-related cause, with risk rising at moderate and high gabapentin doses (Gomes et al., 2017). Watch for: unusual sleepiness, slow or shallow breathing, confusion, especially when either drug is started or increased.

Two of the five pairs never change each other's blood levels at all; the harm comes from effects that add up, which an interaction checker may describe in a single line.

What this part is doingPointing out that pharmacodynamic interactions can be dangerous without any change in levels corrects a common student assumption.
3

Pair 4: Allopurinol and Azathioprine

Type: pharmacokinetic. Mechanism: azathioprine is converted to mercaptopurine, which is broken down by the enzyme xanthine oxidase. Allopurinol, used for gout, blocks xanthine oxidase, so mercaptopurine builds up. Consequence: severe suppression of the bone marrow, with low white cell counts. Watch for: infections, unusual bruising, falling blood counts; if the combination is unavoidable, the azathioprine dose is markedly reduced by the prescriber (Lilley et al., 2023).

Pair 5: Fluoxetine and Metoprolol

Type: pharmacokinetic. Mechanism: metoprolol is broken down mainly by CYP2D6, which fluoxetine strongly inhibits. Metoprolol levels rise. Consequence: a slower heart rate and lower blood pressure than expected. Watch for: dizziness, fatigue, a pulse slower than usual.

Timing Matters

Interactions do not all appear at once. Enzyme inhibition, as in pairs 1, 4 and 5, can raise levels within a day or two of starting the inhibitor, so the first days of a new prescription are the riskiest. The potassium interaction in pair 2 can develop over several days of an antibiotic course, which is why a blood test during or soon after the course may be needed in people at risk. The sedation in pair 3 is greatest when either drug is started or its dose is raised. For allied health staff who take histories, this means a new prescription in the last week is worth asking about, even if the patient has taken the older drug safely for years.

A Food and Herbal Note

Interactions are not limited to prescriptions. Grapefruit juice inhibits a gut enzyme that breaks down some drugs, including several calcium channel blockers and statins, and can raise their levels. St. John's wort, an herbal product taken for low mood, does the opposite for many drugs, speeding their breakdown and lowering their effect, and it can add to the serotonin effects of antidepressants such as fluoxetine. Patients often do not mention herbal products unless asked directly, so a medication history should include them (Lilley et al., 2023).

What the Pairs Have in Common for Practice

Every pair here involves a common drug that a patient might receive from a different prescriber than the one managing the other drug: an antibiotic from urgent care, a pain medicine after surgery, a gout medicine from primary care. Interactions often slip through at these handoffs, when no single clinician sees the whole list. A complete, current medication list, checked at every visit, is the simplest defense.

Patterns

Three of the five pairs are pharmacokinetic and share a pattern: one drug blocks the enzyme that clears the other. Two are pharmacodynamic, and both involve effects that add together, on potassium or on breathing. Knowing the enzyme or the shared effect predicts what to watch for.

Using Interaction Checkers

An interaction checker flags that an interaction exists but rarely explains why. Working out the mechanism tells a clinician what to monitor and how urgent the concern is.

What this part is doingEnding on how mechanism guides monitoring connects the classification exercise to practice.
4

References

Antoniou, T., Gomes, T., Mamdani, M. M., Yao, Z., Hellings, C., Garg, A. X., Weir, M. A., & Juurlink, D. N. (2011). Trimethoprim-sulfamethoxazole induced hyperkalaemia in elderly patients receiving spironolactone: Nested case-control study. BMJ, 343, d5228. https://doi.org/10.1136/bmj.d5228

Gomes, T., Juurlink, D. N., Antoniou, T., Mamdani, M. M., Paterson, J. M., & van den Brink, W. (2017). Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case-control study. PLOS Medicine, 14(10), e1002396. https://doi.org/10.1371/journal.pmed.1002396

Granfors, M. T., Backman, J. T., Neuvonen, M., & Neuvonen, P. J. (2004). Ciprofloxacin greatly increases concentrations and hypotensive effect of tizanidine by inhibiting its cytochrome P450 1A2-mediated presystemic metabolism. Clinical Pharmacology & Therapeutics, 76(6), 598-606. https://doi.org/10.1016/j.clpt.2004.08.018

Katzung, B. G., & Vanderah, T. W. (Eds.). (2021). Basic and clinical pharmacology (15th ed.). McGraw Hill.

Lilley, L. L., Collins, S. R., & Snyder, J. S. (2023). Pharmacology and the nursing process (10th ed.). Elsevier.

HS140 Unit 5 instructions, in plain terms

The fifth unit usually asks students to analyze several drug interactions, classifying each and explaining its mechanism, consequence and what should be monitored. Three to six pairs on two to four pages is common. Instructors expect students to ask what changes, the amount of drug in the blood or the drug's effect, to decide the type. Naming the specific enzyme, transporter or shared effect earns credit. Citing studies that measured an interaction's harm strengthens the analysis. Many prompts allow food and herbal interactions, which show that interactions are not limited to prescriptions. An online interaction checker can identify pairs, but the explanation must come from pharmacology sources.

Inside the HS140 Unit 5 example

The analysis defines the two types and the question that separates them. Five pairs follow, each with type, mechanism, evidence and what to watch: ciprofloxacin and tizanidine with volunteer data, trimethoprim-sulfamethoxazole and spironolactone with a case-control study, gabapentin and an opioid with a population study, allopurinol and azathioprine, and fluoxetine and metoprolol. The highlighted sentence notes that two pairs cause harm without changing blood levels. Sections cover how quickly interactions appear, grapefruit and St. John's wort, and the handoffs between prescribers where interactions slip through. A patterns section and a note on checkers close the paper. Every pair names the enzyme or shared effect involved, so the monitoring point follows directly from the mechanism.

HS140 Unit 5 rubric: what earns full points

Interaction analyses are commonly graded on correct classification, accurate mechanisms, use of evidence, practical monitoring points and clarity. Correct classification and mechanism usually carry the most weight, since a wrong mechanism leads to wrong monitoring. Evidence earns credit when studies of real-world harm or measured drug levels are cited. Monitoring points score well when they are specific to the mechanism, such as potassium for a potassium-raising pair. Including timing and nonprescription products often distinguishes stronger papers. Organizing by pair and citing sources correctly round out the score. Analyses that copy checker text without explanation usually earn partial credit. Instructors sometimes ask students to rank the pairs by urgency, so a note on which matter most can help.

HS140 Unit 5 help from the desk

The most common error is classifying an interaction by its consequence rather than its mechanism, calling any dangerous pair pharmacodynamic. Another is naming an enzyme without saying which drug blocks it and which drug it clears. Some students list interactions without saying what to watch for. Others overlook additive effects, such as two sedating drugs, because the checker rates them as moderate. Leaving out over-the-counter and herbal products narrows the analysis. If your instructor assigned different pairs or a patient's medication list, send them, and an analysis can be drafted that classifies each pair and explains its mechanism. Citing a checker as the only source for a mechanism is another weakness instructors flag.

Get an HS140 Unit 5 example written to your instructions

Which pairs did your Unit 5 prompt assign, or are you choosing your own? Send them with the instructions and rubric. In 24-48h a custom interaction analysis explaining each pair by mechanism, category and monitoring comes back to you, laid out in your section's format. The first analysis costs nothing. The paper above is an original model document written by our desk, not a submitted student paper and not an official Purdue University Global document.

More HS140 papers and BS in Health Science samples

HS140 Unit 5 questions, answered

How do I know whether an interaction is pharmacokinetic or pharmacodynamic?

Ask what changes. If the amount of drug in the blood rises or falls, because absorption, metabolism or excretion is affected, it is pharmacokinetic. If the levels stay the same but the effects combine or oppose each other, it is pharmacodynamic. A few interactions involve both, and saying so explicitly usually strengthens the analysis rather than complicating it.

Can I use an online interaction checker?

As a starting point, yes, but a checker tells you that an interaction exists, not why. The analysis needs the mechanism, which comes from your course text or a drug reference. Cite the reference rather than the checker where possible, and never copy its warning text as your explanation, since graders recognize that and it rarely addresses the rubric.

Should I include food and herbal interactions?

If the prompt allows, they often strengthen the analysis because they show interaction risk extends beyond prescriptions. Grapefruit juice, St. John's wort and foods rich in vitamin K with warfarin are well-documented examples. Treat them with the same structure as drug pairs, mechanism, consequence and monitoring, so they read as analysis rather than as trivia added for length.

Where can I find a free HS140 Unit 5 sample paper?

The complete Unit 5 interaction analysis is shown here, classifying five real drug pairs by mechanism with evidence and monitoring points.

Can an interaction be dangerous without changing drug levels?

Yes. Gabapentin and opioids both depress breathing, and their effects add up even though neither raises the other's blood level.